UNITY Biotechnology (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- October 28, 2016
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $116,000,000
Company Info
- Company Description
- UNITY Biotechnology is developing therapeutics that increase healthspan by preventing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related afflictions such as osteoarthritis, atherosclerosis, eye diseases, and kidney disease.
- Market
- Healthspan and Aging Therapeutics
- Location
- San Francisco, CA, USA
- Coinvestors
- ARCH Venture Partners, Baillie Gifford, Fidelity Investments, Mayo Clinic Ventures, Partner Fund Management, Venrock, WuXi PharmaTech